InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
-1.3%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Edick Paul R, Chief Executive Officer. Director active across 2 companies, notably Xeris Pharmaceuticals INC. Cumulatively, 10 reports have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €586k. History available since 11 November 2021. The latest transaction was disclosed on 31 January 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Edick Paul R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
1,500,000 shares0Common StockSEC:0001867096-24-000014:0
10,000 shares@ US$2.37942.2% of flowCommon StockSEC:0001867096-23-000117:0
Canonical exit: 7 Nov 2023 (T+90)
750,000 shares0Common StockSEC:0001867096-23-000023:0
20,000 shares@ US$1.452.8% of flowCommon StockSEC:0001867096-22-000131:0
Canonical exit: 13 Mar 2023 (T+90)
100,000 shares@ US$1.403823.1% of flowCommon StockSEC:0001867096-22-000067:0
Canonical exit: 10 Aug 2022 (T+90)
600,000 shares0Common StockSEC:0001867096-22-000007:0
20,000 shares@ US$2.28326.8% of flowCommon StockSEC:0001867096-21-000080:0
Canonical exit: 13 Feb 2022 (T+90)
200,000 shares@ US$2.078861.7% of flowCommon StockSEC:0001867096-21-000076:0
Canonical exit: 9 Feb 2022 (T+90)
197,231 sharesCommon StockSEC:0000899243-21-039254:0
197,231 sharesCommon StockSEC:0000899243-21-039335:0
10 of 10 declarations
About Edick Paul R
Edick Paul R is Directeur Général. He has filed 10 filings in total, and in the 10 sampled recent filings, the transactions are acquisitions, with EUR 586314 of buys and EUR 0 of sells between 2021-10-05 and 2024-01-31. He is linked to Xeris Biopharma Holdings, Inc. and Xeris Pharmaceuticals INC.
